Vertex Pharmaceuticals
VRTX
#186
Rank
NZ$200.21 B
Marketcap
NZ$780.90
Share price
-1.26%
Change (1 day)
5.87%
Change (1 year)

Vertex Pharmaceuticals (VRTX) - P/B ratio

P/B ratio as of January 2026 : 6.73

According to Vertex Pharmaceuticals's latest financial reports the company has a price-to-book ratio of 9.94371.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.

Vertex Pharmaceuticals - P/B ratio (from 2001 to 2025)

P/B ratio by year

Year P/B ratio Change
2025-12-316.856.83%
2024-12-316.417.56%
2023-12-315.9611.94%
2022-12-315.33-3.71%
2021-12-315.53-21.79%
2020-12-317.07-24.08%
2019-12-319.32-2.26%
2018-12-319.53-48.63%
2017-12-3118.635.91%
2016-12-3113.7-51.82%
2015-12-3128.38.16%
2014-12-3126.2104.6%
2013-12-3112.868.21%
2012-12-317.612.05%
2011-12-317.46-47.27%
2010-12-3114.181.01%
2009-12-317.82-56.58%
2008-12-3118.058.2%
2007-12-3111.421.97%
2006-12-319.33-25.45%
2005-12-3112.5-48.06%
2004-12-3124.1475.21%
2003-12-314.1930.99%
2002-12-313.20

P/B ratio for similar companies or competitors

Company P/B ratio P/B ratio differencediff. Country
Gilead Sciences
GILD
7.04 4.61%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
-150-2,330.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
5.21-22.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
6.12-9.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
6.49-3.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Enanta Pharmaceuticals
ENTA
5.86-13.00%๐Ÿ‡บ๐Ÿ‡ธ USA